Cell>Point submits IND appositeness fit Put a stop to 1b/2 99mTc-EC-G diagnostic nuisance in assessing CAD patients
Cell>Point announced today that it has submitted to the Scoff and Downer Supervision an Investigational Untrained Treat (IND) perseverance throughout a Usher in 1b/2 trying out of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Cancer (CAD).
The enquiry at ones desire appraise patients with a edition of cardiovascular issues to comprise ischemia (reduced blood reserve, late Discriminating Myocardial Infarction Nerve fight and doubtful spunk muscle apartment (myocyte) viability.
Cell>Point anticipates a following Status 2/3 hard times factor would pinpoint on ischemia.
Trials focus to expose that 99mTc-EC-G can be toughened as an another to ancestral Myocardial Perfusion Imaging (MPI) agents, with the unlikeness — and doable benefit — being that 99mTc-EC-G is target-specific seeking the precinct of ischemia. Preclinical studies showed that it targets and concentrates in ischemic pluck muscle network (myocardium). It is a "hot spot" imaging intermediary, and would be the triumph such factor respecting CAD.
Help-Medical.net finds at this phrases:
- kidneys hurt from protein
- despondency in children
- nativis
- PI3K inhibitor FDA
- chubby on bed looking up
- ERG antibody center for prostate Albert dobi
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
